M-14013 Carbohydrate Antigen 125 (CA125) Quantitative Test Kit

Clinical Significance: Carbohydrate antigen CA125 is a tumor marker for various cancers including epithelial ovarian cancer, endometrial cancer, fallopian tube cancer, and lung cancer. The cutoff value is generally 35 KU/L. In patients with ovarian cancer, lung cancer, cervical cancer, and other cancers, this marker is significantly elevated. In 95% of healthy adult women, CA125 levels are ≤35 U/ml.
Product Specifications: 20 tests per box
Product Shelf Life: Sealed in an aluminum foil bag, the product is valid for 18 months. Once opened, the aluminum foil bag should be used within 1 hour.
Product Storage: Store the test cards at 2°C to 30°C.
 
Usage Scenarios:
Hospitals and Oncology Departments: For diagnosing and monitoring various cancers such as epithelial ovarian cancer, endometrial cancer, fallopian tube cancer, and lung cancer by tracking CA125 levels.
Gynecology Clinics: For regular screening and monitoring of CA125 levels in women at risk of ovarian and other gynecological cancers.
Diagnostic Laboratories: For routine testing of serum CA125 levels as part of a comprehensive cancer diagnosis and management program.
Cancer Screening Programs: For early detection and monitoring of high-risk populations for cancers associated with elevated CA125 levels.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are widely used for comprehensive cancer management and early detection.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving diagnostic capabilities for cancer and expanding access to modern diagnostic tools.
Global Health Programs: International health initiatives focused on enhancing cancer detection and management in low-resource settings.